Abingdon Health Plc (AIM:ABDX)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
9.00
0.00 (0.00%)
Oct 23, 2026, 9:52 AM BST

Abingdon Health Revenue

In the fiscal year ending June 30, 2026, Abingdon Health had annual revenue of 10.99M GBP with 30.42% growth. Abingdon Health had revenue of 6.76M in the half year ending June 30, 2026, with 81.37% growth. That makes Abingdon Health the 35,477th largest company in the world by revenue and 698th in the United Kingdom.

Revenue
10.99M
Revenue Growth
+30.42%
P/S Ratio
3.56
Revenue / Employee
83.92K
Employees
131
Market Cap
39.16M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Contract Development 4.99M 45.4%
  • Regulatory 4.13M 37.6%
  • Contract Manufacturing 1.27M 11.6%
  • Product Sales 604.00K 5.5%

By Geography

Chart
  • Europe 4.21M 38.3%
  • USA & Canada 3.75M 34.1%
  • United Kingdom 2.84M 25.8%
  • Rest of The World 187.00K 1.7%
Fiscal year ended Jun 30, 2026 See the full Abingdon Health breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202610.99M2.56M30.42%
Jun 30, 20258.43M2.29M37.39%
Jun 30, 20246.14M2.09M51.67%
Jun 30, 20234.05M1.21M42.68%
Jun 30, 20222.84M-8.78M-75.60%
Jun 30, 202111.62M6.38M121.93%
Jun 30, 20205.24M2.96M129.88%
Jun 30, 20192.28M886.65K63.76%
Dec 31, 20161.39M272.59K24.38%
Dec 31, 20151.12M-62.67K-5.31%
Dec 31, 20141.18M-688.02K-36.82%
Dec 31, 20131.87M1.09M138.72%
Dec 31, 2012782.81K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
AstraZeneca46.25B
GSK plc33.20B
Haleon11.15B
Smith & Nephew4.77B
BATM Advanced Communications78.81M
hVIVO42.09M
Renalytix2.45M
Arecor Therapeutics890.00K
Revenue Rankings